Research Roundup brings together research opportunities currently open on Inspire, all in one place. By participating in research, members help advance science and give researchers a clearer understanding of what it's really like to live with different health conditions.

Your experiences can help inform future care, treatments, and support for others.

Every research study is different. Some focus on evaluating treatments, while others aim to better understand symptoms, daily experiences, or quality of life. Because of that, each study has its own purpose and eligibility requirements. Not every opportunity will be the right fit — and that's okay.

Each listing includes a brief overview and a link to learn more about the study and see if you may qualify.

• 18 years of age and older
• Diagnosed with Sjögren's disease for at least 6 months
• Experiencing signs or symptoms of Sjögren's despite having tried other treatments

• 18 years of age and older
• Diagnosed with moderate or severe HS for at least 6 months
• Have at least 5 nodules and/or abscesses lesions on 2 different areas of their body

• Aged 18 or older
• Have SLE diagnosed by a rheumatologist
• Started taking Benlysta® (belimumab) in the last six months
• Reside and receive care in the U.S.

• Patients with diagnosed heart failure and impaired kidney function
• Trial-related procedures and study medication will be provided at no cost

• Are 18-70 years old
• Have been diagnosed with ulcerative colitis
• Have a BMI ≥30
• Or have a BMI ≥27 with high blood pressure, type 2 diabetes, dyslipidemia (abnormal fat levels in blood), obstructive sleep apnea, or heart disease

• Patients with diagnosed heart failure and impaired kidney function
• Trial-related procedures and study medication will be provided at no cost

• Are 18 years of age or older
• Diagnosed with Primary Biliary Cholangitis and Liver Cirrhosis

• Aged 18 or older
• Earn up to $660 for your participation
• Diagnosis of CIDP, regardless of symptom or treatment history
• Not currently on Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
• US-based with a proficient understanding of and ability to comprehend study materials

• Aged 18 or older
• Diagnosis with CIDP
• Receiving medical care in the U.S.
• Currently on treatment for CIDP for at least 3 months
• Not enrolled in an interventional clinical trial for a new CIDP medication at the time of enrollment

• Diagnosed with CIDP
• Receiving medical care in the U.S.
• Age 18+
• Compensation: $100 for your time spent enrolling upon confirmation of eligibility and up to $380 per year for time spent completing surveys

• Are you or your child 12 years or older
• If you are under 18 years old, your legal guardian must complete the questionnaire for you
• Have a confirmed diagnosis of focal onset seizures (FOS) for two or more years OR
• Have experienced primary generalized tonic-clonic seizures (PGTCS) for at least 1 year

• Aged 18 to 75 years
• Diagnosed and taking medication for MDD and willing to continue with that medication
• Feeling better with your current treatment
• Have a body mass index (BMI) of at least 22 kg/m2

• Aged 18 to 85
• Diagnosed with MDD
• Have been taking an antidepressant medication at a consistent dose
• Do not have any psychotic disorder, such as schizophrenia or bipolar disorder

• You are 50+ years old and due for a screening colonoscopy
• You are willing to provide a blood sample as part of the study
• You complete a screening colonoscopy during the study period
• You want to earn $325 - $475 in electronic payment card compensation for your time and effort

• Looking for individuals with relapsed or refractory leukemia and lymphoma
• Are between the ages of 18 and 90
• This study doesn't require insurance for study-related procedures or treatments and offers reimbursement for travel to research sites

• Adult patient (≥18 years old) diagnosed with EoE OR
• Caregiver of a pediatric patient (ages 11-17 years old) diagnosed with EoE
• U.S. as country of residence
• Ability to provide study consent and complete study survey(s)

• 18 years of age or older
• Diagnosis of PKU or providing care for a loved one diagnosed with PKU